PMID- 37125906 OWN - NLM STAT- MEDLINE DCOM- 20230619 LR - 20231120 IS - 2165-0497 (Electronic) IS - 2165-0497 (Linking) VI - 11 IP - 3 DP - 2023 Jun 15 TI - Leishmania donovani Attenuates Dendritic Cell Trafficking to Lymph Nodes by Inhibiting C-Type Lectin Receptor 2 Expression via Transforming Growth Factor-beta. PG - e0412222 LID - 10.1128/spectrum.04122-22 [doi] LID - e04122-22 AB - To initiate an antileishmanial adaptive immune response, dendritic cells (DCs) must carry Leishmania antigens from peripheral tissues to local draining lymph nodes. However, the migratory capacity of DCs is largely compromised during Leishmania donovani infection. The molecular mechanism underlying this defective DC migration is not yet fully understood. Here, we demonstrate that L. donovani infection impaired the lymph node homing ability of DCs by decreasing C-type lectin receptor 2 (CLEC-2) expression. L. donovani exerted this inhibitory effect by inducing transforming growth factor-beta (TGF-beta) secretion from DCs. Indeed, TGF-beta produced in this manner inhibited nuclear factor-kappaB (NF-kappaB)-mediated CLEC-2 expression on DCs by activating c-Src. Notably, suppression of c-Src expression significantly improved the arrival of DCs in draining lymph nodes by preventing L. donovani-induced CLEC-2 downregulation on DCs. These findings reveal a unique mechanism by which L. donovani inhibits DC migration to lymph nodes and suggest a key role for TGF-beta, c-Src, and CLEC-2 in regulating this process. IMPORTANCE Dendritic cells (DCs) play a key role in initiating T cell-mediated protective immunity against visceral leishmaniasis (VL), the second most lethal parasitic disease in the world. However, the T cell-inducing ability of DCs critically depends on the extent of DC migration to regional lymph nodes. Notably, the migration of DCs is reported to be impaired during VL. The cause of this impaired DC migration, however, remains ill-defined. Here, we provide the first evidence that L. donovani, the causative agent of VL, attenuates the lymph node homing capacity of DCs by decreasing C-type lectin receptor 2 (CLEC-2) expression on DCs. Additionally, we have demonstrated how L. donovani mediates this inhibitory effect. Overall, our work has revealed a unique mechanism underlying L. donovani-induced impairment of DC migration and suggests a potential strategy to improve antileishmanial T cell activity by increasing DC arrival in lymph nodes. FAU - Yadav, Manisha AU - Yadav M AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. FAU - Akhtar, Md Naushad AU - Akhtar MN AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. FAU - Mishra, Manish AU - Mishra M AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. FAU - Kumar, Sandeep AU - Kumar S AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. AD - Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. FAU - Kumar, Raj AU - Kumar R AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. FAU - Shubham AU - Shubham AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. AD - Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. FAU - Nandal, Anil AU - Nandal A AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. FAU - Sen, Pradip AU - Sen P AUID- ORCID: 0000-0003-1712-5312 AD - Division of Cell Biology and Immunology, Council of Scientific and Industrial Research-Institute of Microbial Technology, Chandigarh, India. AD - Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230501 PL - United States TA - Microbiol Spectr JT - Microbiology spectrum JID - 101634614 RN - 0 (Transforming Growth Factor beta) RN - 0 (Lectins, C-Type) RN - 0 (Antiprotozoal Agents) RN - 76057-06-2 (Transforming Growth Factors) SB - IM MH - Humans MH - *Leishmania donovani/metabolism MH - Transforming Growth Factor beta/metabolism MH - Lectins, C-Type/genetics/metabolism MH - *Leishmaniasis, Visceral/metabolism/parasitology MH - *Antiprotozoal Agents MH - Lymph Nodes/metabolism MH - Dendritic Cells MH - Transforming Growth Factors/metabolism PMC - PMC10269552 OTO - NOTNLM OT - CLEC-2 OT - Leishmania donovani OT - NF-kappaB OT - TGF-beta OT - c-Src OT - dendritic cell trafficking COIS- The authors declare no conflict of interest. EDAT- 2023/05/01 12:44 MHDA- 2023/06/19 13:08 PMCR- 2023/05/01 CRDT- 2023/05/01 10:06 PHST- 2023/06/19 13:08 [medline] PHST- 2023/05/01 12:44 [pubmed] PHST- 2023/05/01 10:06 [entrez] PHST- 2023/05/01 00:00 [pmc-release] AID - 04122-22 [pii] AID - spectrum.04122-22 [pii] AID - 10.1128/spectrum.04122-22 [doi] PST - ppublish SO - Microbiol Spectr. 2023 Jun 15;11(3):e0412222. doi: 10.1128/spectrum.04122-22. Epub 2023 May 1.